| Synonyms: | |
| Status: | Approved (1978) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C01CA07 |
| UNII: | 3S12J47372 |
| InChI Key | JRWZLRBJNMZMFE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H23NO3 |
| Molecular Weight | 301.39 |
| AlogP | 2.96 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 72.72 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 22.0 |
| Primary Target | |
|---|---|
| β1-adrenoceptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Lyase
|
- | - | - | 12020 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 4170 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cardiovascular Diseases | 4 | D002318 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Shock, Septic | 2 | D012772 | ClinicalTrials |
| Acute Lung Injury | 2 | D055371 | ClinicalTrials |
| Shock | 2 | D012769 | ClinicalTrials |
| Brain Injuries | 2 | D001930 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 34368-04-2 |
| ChEBI | 4670 |
| ChEMBL | CHEMBL926 |
| DrugBank | DB00841 |
| DrugCentral | 937 |
| EPA CompTox | DTXSID3022958 |
| FDA SRS | 3S12J47372 |
| Human Metabolome Database | HMDB0014979 |
| Guide to Pharmacology | 535 |
| KEGG | C06967 |
| PharmGKB | PA449381 |
| PubChem | 36811 |
| SureChEMBL | SCHEMBL21237 |